Global market

  • Colorectal (CRC) is the worldwide third leading cancer in incidence and mortality, according the WHO.
  • European guidelines recommend CRC prevention based on screening the population risk (all 50-75-years-old population).
  • The current organized screening programs use Immunological Fecal occult blood Test (FIT) base on detecting blood in feces. But, because blood is not a specific marker of CRC, using FIT in its maximum sensitivity implies an high rate of false positive and induce a large amount of unnecessary colonoscopies.
  • Specific non-invasive screening tools focused on detection at early stages become a keystone in order to prevent CRC.

Our proposal

RAID-CRC is a patented non-invasive system that complements FIT screening with determination CRC microbiological signature in fecal sample.

In 2018 we aim to perform a clinical validation in German screening population and launch RAID-CRC to the market in 2019 with total financial needs of 4 million euros.

Funding from:


Healthio 2018

Healthio 2018

By goodgut.eu, On 17 de October de 2018

GoodGut is to present its non-invasive tests to support the diagnosis and treatment ...

2019 InSiGHT Meeting

2019 InSiGHT Meeting

By goodgut.eu, On 20 de March de 2019

The International Society for Gastrointestinal Hereditary Tumours (InSiGHT) and the New Zealand Society ...